Influenza Vaccine Effectiveness Against Illness and Asymptomatic Infection in 2022–2023: A Prospective Cohort Study Article Swipe
Elizabeth B. White
,
Lauren Grant
,
Josephine Mak
,
Lauren E.W. Olsho
,
Laura Edwards
,
Allison L. Naleway
,
Jefferey L. Burgess
,
Katherine Ellingson
,
Harmony L. Tyner
,
Manjusha Gaglani
,
Karen Lutrick
,
Alberto J. Caban‐Martinez
,
Gabriella Newes‐Adeyi
,
Jazmin Duque
,
Sarang K. Yoon
,
Andrew L. Phillips
,
Mark S. Thompson
,
Amadea Britton
,
Brendan Flannery
,
Ashley Fowlkes
·
YOU?
·
· 2024
· Open Access
·
· DOI: https://doi.org/10.1093/cid/ciae491
YOU?
·
· 2024
· Open Access
·
· DOI: https://doi.org/10.1093/cid/ciae491
Background Previous estimates of vaccine effectiveness (VE) against asymptomatic influenza virus infection based on seroconversion have varied widely and may be biased. We estimated 2022–2023 influenza VE against illness and asymptomatic infection in a prospective cohort. Methods In the HEROES-RECOVER cohort, adults at increased occupational risk of influenza exposure across 7 US sites provided weekly symptom reports and nasal swabs for reverse transcription–polymerase chain reaction (RT-PCR) influenza testing. Laboratory-confirmed influenza virus infections were classified as symptomatic (≥1 symptom) or asymptomatic during the week of testing. Participants reported demographic information and vaccination through surveys; most sites verified vaccination through medical record and immunization registry review. Person-time was calculated as days from the site-specific influenza season start (September–October 2022) through date of infection, study withdrawal, or season end (May 2023). We compared influenza incidence among vaccinated versus unvaccinated participants overall, by symptom status, and by influenza A subtype, using Cox proportional hazards regression adjusted for site and occupation. We estimated VE as (1 − adjusted hazard ratio) × 100%. Results In total, 269 of 3785 (7.1%) participants had laboratory-confirmed influenza, including 263 (98%) influenza A virus infections and 201 (75%) symptomatic illnesses. Incidence of laboratory-confirmed influenza illness among vaccinated versus unvaccinated participants was 23.7 and 33.2 episodes per 100 000 person-days, respectively (VE: 38%; 95% CI: 15%–55%). Incidence of asymptomatic influenza virus infection was 8.0 versus 11.6 per 100 000 (VE: 13%; 95% CI: −47%, 49%). Conclusions Vaccination reduced incidence of symptomatic but not asymptomatic influenza virus infection, suggesting that influenza vaccination attenuates progression from infection to illness.
Related Topics
Concepts
Metadata
- Type
- article
- Language
- en
- Landing Page
- https://doi.org/10.1093/cid/ciae491
- https://academic.oup.com/cid/advance-article-pdf/doi/10.1093/cid/ciae491/60029679/ciae491.pdf
- OA Status
- bronze
- Cited By
- 6
- References
- 24
- Related Works
- 10
- OpenAlex ID
- https://openalex.org/W4403707234
All OpenAlex metadata
Raw OpenAlex JSON
- OpenAlex ID
-
https://openalex.org/W4403707234Canonical identifier for this work in OpenAlex
- DOI
-
https://doi.org/10.1093/cid/ciae491Digital Object Identifier
- Title
-
Influenza Vaccine Effectiveness Against Illness and Asymptomatic Infection in 2022–2023: A Prospective Cohort StudyWork title
- Type
-
articleOpenAlex work type
- Language
-
enPrimary language
- Publication year
-
2024Year of publication
- Publication date
-
2024-10-23Full publication date if available
- Authors
-
Elizabeth B. White, Lauren Grant, Josephine Mak, Lauren E.W. Olsho, Laura Edwards, Allison L. Naleway, Jefferey L. Burgess, Katherine Ellingson, Harmony L. Tyner, Manjusha Gaglani, Karen Lutrick, Alberto J. Caban‐Martinez, Gabriella Newes‐Adeyi, Jazmin Duque, Sarang K. Yoon, Andrew L. Phillips, Mark S. Thompson, Amadea Britton, Brendan Flannery, Ashley FowlkesList of authors in order
- Landing page
-
https://doi.org/10.1093/cid/ciae491Publisher landing page
- PDF URL
-
https://academic.oup.com/cid/advance-article-pdf/doi/10.1093/cid/ciae491/60029679/ciae491.pdfDirect link to full text PDF
- Open access
-
YesWhether a free full text is available
- OA status
-
bronzeOpen access status per OpenAlex
- OA URL
-
https://academic.oup.com/cid/advance-article-pdf/doi/10.1093/cid/ciae491/60029679/ciae491.pdfDirect OA link when available
- Concepts
-
Medicine, Asymptomatic, Seroconversion, Vaccination, Incidence (geometry), Prospective cohort study, Influenza vaccine, Cohort study, Hazard ratio, Internal medicine, Cohort, Immunology, Virus, Confidence interval, Physics, OpticsTop concepts (fields/topics) attached by OpenAlex
- Cited by
-
6Total citation count in OpenAlex
- Citations by year (recent)
-
2025: 6Per-year citation counts (last 5 years)
- References (count)
-
24Number of works referenced by this work
- Related works (count)
-
10Other works algorithmically related by OpenAlex
Full payload
| id | https://openalex.org/W4403707234 |
|---|---|
| doi | https://doi.org/10.1093/cid/ciae491 |
| ids.doi | https://doi.org/10.1093/cid/ciae491 |
| ids.pmid | https://pubmed.ncbi.nlm.nih.gov/39446477 |
| ids.openalex | https://openalex.org/W4403707234 |
| fwci | 5.52931863 |
| mesh[0].qualifier_ui | |
| mesh[0].descriptor_ui | D006801 |
| mesh[0].is_major_topic | False |
| mesh[0].qualifier_name | |
| mesh[0].descriptor_name | Humans |
| mesh[1].qualifier_ui | Q000517 |
| mesh[1].descriptor_ui | D007251 |
| mesh[1].is_major_topic | True |
| mesh[1].qualifier_name | prevention & control |
| mesh[1].descriptor_name | Influenza, Human |
| mesh[2].qualifier_ui | Q000453 |
| mesh[2].descriptor_ui | D007251 |
| mesh[2].is_major_topic | True |
| mesh[2].qualifier_name | epidemiology |
| mesh[2].descriptor_name | Influenza, Human |
| mesh[3].qualifier_ui | Q000276 |
| mesh[3].descriptor_ui | D007252 |
| mesh[3].is_major_topic | True |
| mesh[3].qualifier_name | immunology |
| mesh[3].descriptor_name | Influenza Vaccines |
| mesh[4].qualifier_ui | Q000008 |
| mesh[4].descriptor_ui | D007252 |
| mesh[4].is_major_topic | True |
| mesh[4].qualifier_name | administration & dosage |
| mesh[4].descriptor_name | Influenza Vaccines |
| mesh[5].qualifier_ui | |
| mesh[5].descriptor_ui | D011446 |
| mesh[5].is_major_topic | False |
| mesh[5].qualifier_name | |
| mesh[5].descriptor_name | Prospective Studies |
| mesh[6].qualifier_ui | |
| mesh[6].descriptor_ui | D008297 |
| mesh[6].is_major_topic | False |
| mesh[6].qualifier_name | |
| mesh[6].descriptor_name | Male |
| mesh[7].qualifier_ui | |
| mesh[7].descriptor_ui | D005260 |
| mesh[7].is_major_topic | False |
| mesh[7].qualifier_name | |
| mesh[7].descriptor_name | Female |
| mesh[8].qualifier_ui | |
| mesh[8].descriptor_ui | D008875 |
| mesh[8].is_major_topic | False |
| mesh[8].qualifier_name | |
| mesh[8].descriptor_name | Middle Aged |
| mesh[9].qualifier_ui | |
| mesh[9].descriptor_ui | D000328 |
| mesh[9].is_major_topic | False |
| mesh[9].qualifier_name | |
| mesh[9].descriptor_name | Adult |
| mesh[10].qualifier_ui | Q000453 |
| mesh[10].descriptor_ui | D058345 |
| mesh[10].is_major_topic | True |
| mesh[10].qualifier_name | epidemiology |
| mesh[10].descriptor_name | Asymptomatic Infections |
| mesh[11].qualifier_ui | |
| mesh[11].descriptor_ui | D000087507 |
| mesh[11].is_major_topic | True |
| mesh[11].qualifier_name | |
| mesh[11].descriptor_name | Vaccine Efficacy |
| mesh[12].qualifier_ui | |
| mesh[12].descriptor_ui | D000368 |
| mesh[12].is_major_topic | False |
| mesh[12].qualifier_name | |
| mesh[12].descriptor_name | Aged |
| mesh[13].qualifier_ui | |
| mesh[13].descriptor_ui | D015994 |
| mesh[13].is_major_topic | False |
| mesh[13].qualifier_name | |
| mesh[13].descriptor_name | Incidence |
| mesh[14].qualifier_ui | Q000453 |
| mesh[14].descriptor_ui | D014481 |
| mesh[14].is_major_topic | False |
| mesh[14].qualifier_name | epidemiology |
| mesh[14].descriptor_name | United States |
| mesh[15].qualifier_ui | Q000706 |
| mesh[15].descriptor_ui | D014611 |
| mesh[15].is_major_topic | False |
| mesh[15].qualifier_name | statistics & numerical data |
| mesh[15].descriptor_name | Vaccination |
| mesh[16].qualifier_ui | |
| mesh[16].descriptor_ui | D055815 |
| mesh[16].is_major_topic | False |
| mesh[16].qualifier_name | |
| mesh[16].descriptor_name | Young Adult |
| mesh[17].qualifier_ui | Q000276 |
| mesh[17].descriptor_ui | D009980 |
| mesh[17].is_major_topic | False |
| mesh[17].qualifier_name | immunology |
| mesh[17].descriptor_name | Influenza A virus |
| type | article |
| title | Influenza Vaccine Effectiveness Against Illness and Asymptomatic Infection in 2022–2023: A Prospective Cohort Study |
| biblio.issue | 4 |
| biblio.volume | 80 |
| biblio.last_page | 900 |
| biblio.first_page | 893 |
| topics[0].id | https://openalex.org/T10167 |
| topics[0].field.id | https://openalex.org/fields/27 |
| topics[0].field.display_name | Medicine |
| topics[0].score | 1.0 |
| topics[0].domain.id | https://openalex.org/domains/4 |
| topics[0].domain.display_name | Health Sciences |
| topics[0].subfield.id | https://openalex.org/subfields/2713 |
| topics[0].subfield.display_name | Epidemiology |
| topics[0].display_name | Influenza Virus Research Studies |
| topics[1].id | https://openalex.org/T10118 |
| topics[1].field.id | https://openalex.org/fields/27 |
| topics[1].field.display_name | Medicine |
| topics[1].score | 0.9945999979972839 |
| topics[1].domain.id | https://openalex.org/domains/4 |
| topics[1].domain.display_name | Health Sciences |
| topics[1].subfield.id | https://openalex.org/subfields/2725 |
| topics[1].subfield.display_name | Infectious Diseases |
| topics[1].display_name | SARS-CoV-2 and COVID-19 Research |
| topics[2].id | https://openalex.org/T11243 |
| topics[2].field.id | https://openalex.org/fields/27 |
| topics[2].field.display_name | Medicine |
| topics[2].score | 0.9941999912261963 |
| topics[2].domain.id | https://openalex.org/domains/4 |
| topics[2].domain.display_name | Health Sciences |
| topics[2].subfield.id | https://openalex.org/subfields/2713 |
| topics[2].subfield.display_name | Epidemiology |
| topics[2].display_name | Respiratory viral infections research |
| funders[0].id | https://openalex.org/F4320310160 |
| funders[0].ror | https://ror.org/03m2x1q45 |
| funders[0].display_name | University of Arizona |
| funders[1].id | https://openalex.org/F4320310794 |
| funders[1].ror | https://ror.org/0502afh35 |
| funders[1].display_name | Abt Associates |
| funders[2].id | https://openalex.org/F4320312904 |
| funders[2].ror | |
| funders[2].display_name | Marshfield Clinic Research Institute |
| funders[3].id | https://openalex.org/F4320332162 |
| funders[3].ror | https://ror.org/042twtr12 |
| funders[3].display_name | Centers for Disease Control and Prevention |
| funders[4].id | https://openalex.org/F4320337421 |
| funders[4].ror | https://ror.org/05je2tx78 |
| funders[4].display_name | National Center for Immunization and Respiratory Diseases |
| is_xpac | False |
| apc_list.value | 4320 |
| apc_list.currency | USD |
| apc_list.value_usd | 4320 |
| apc_paid | |
| concepts[0].id | https://openalex.org/C71924100 |
| concepts[0].level | 0 |
| concepts[0].score | 0.9104306101799011 |
| concepts[0].wikidata | https://www.wikidata.org/wiki/Q11190 |
| concepts[0].display_name | Medicine |
| concepts[1].id | https://openalex.org/C2777910003 |
| concepts[1].level | 2 |
| concepts[1].score | 0.793002188205719 |
| concepts[1].wikidata | https://www.wikidata.org/wiki/Q1707292 |
| concepts[1].display_name | Asymptomatic |
| concepts[2].id | https://openalex.org/C2777451964 |
| concepts[2].level | 3 |
| concepts[2].score | 0.7122583389282227 |
| concepts[2].wikidata | https://www.wikidata.org/wiki/Q2141450 |
| concepts[2].display_name | Seroconversion |
| concepts[3].id | https://openalex.org/C22070199 |
| concepts[3].level | 2 |
| concepts[3].score | 0.6982629299163818 |
| concepts[3].wikidata | https://www.wikidata.org/wiki/Q192995 |
| concepts[3].display_name | Vaccination |
| concepts[4].id | https://openalex.org/C61511704 |
| concepts[4].level | 2 |
| concepts[4].score | 0.5879915952682495 |
| concepts[4].wikidata | https://www.wikidata.org/wiki/Q1671857 |
| concepts[4].display_name | Incidence (geometry) |
| concepts[5].id | https://openalex.org/C188816634 |
| concepts[5].level | 2 |
| concepts[5].score | 0.5810328722000122 |
| concepts[5].wikidata | https://www.wikidata.org/wiki/Q2113324 |
| concepts[5].display_name | Prospective cohort study |
| concepts[6].id | https://openalex.org/C2780689484 |
| concepts[6].level | 3 |
| concepts[6].score | 0.5309022665023804 |
| concepts[6].wikidata | https://www.wikidata.org/wiki/Q383260 |
| concepts[6].display_name | Influenza vaccine |
| concepts[7].id | https://openalex.org/C201903717 |
| concepts[7].level | 2 |
| concepts[7].score | 0.4856092035770416 |
| concepts[7].wikidata | https://www.wikidata.org/wiki/Q1778788 |
| concepts[7].display_name | Cohort study |
| concepts[8].id | https://openalex.org/C207103383 |
| concepts[8].level | 3 |
| concepts[8].score | 0.4823422133922577 |
| concepts[8].wikidata | https://www.wikidata.org/wiki/Q3930246 |
| concepts[8].display_name | Hazard ratio |
| concepts[9].id | https://openalex.org/C126322002 |
| concepts[9].level | 1 |
| concepts[9].score | 0.467384934425354 |
| concepts[9].wikidata | https://www.wikidata.org/wiki/Q11180 |
| concepts[9].display_name | Internal medicine |
| concepts[10].id | https://openalex.org/C72563966 |
| concepts[10].level | 2 |
| concepts[10].score | 0.4576683044433594 |
| concepts[10].wikidata | https://www.wikidata.org/wiki/Q1303415 |
| concepts[10].display_name | Cohort |
| concepts[11].id | https://openalex.org/C203014093 |
| concepts[11].level | 1 |
| concepts[11].score | 0.3689524233341217 |
| concepts[11].wikidata | https://www.wikidata.org/wiki/Q101929 |
| concepts[11].display_name | Immunology |
| concepts[12].id | https://openalex.org/C2522874641 |
| concepts[12].level | 2 |
| concepts[12].score | 0.343239426612854 |
| concepts[12].wikidata | https://www.wikidata.org/wiki/Q808 |
| concepts[12].display_name | Virus |
| concepts[13].id | https://openalex.org/C44249647 |
| concepts[13].level | 2 |
| concepts[13].score | 0.1255633533000946 |
| concepts[13].wikidata | https://www.wikidata.org/wiki/Q208498 |
| concepts[13].display_name | Confidence interval |
| concepts[14].id | https://openalex.org/C121332964 |
| concepts[14].level | 0 |
| concepts[14].score | 0.0 |
| concepts[14].wikidata | https://www.wikidata.org/wiki/Q413 |
| concepts[14].display_name | Physics |
| concepts[15].id | https://openalex.org/C120665830 |
| concepts[15].level | 1 |
| concepts[15].score | 0.0 |
| concepts[15].wikidata | https://www.wikidata.org/wiki/Q14620 |
| concepts[15].display_name | Optics |
| keywords[0].id | https://openalex.org/keywords/medicine |
| keywords[0].score | 0.9104306101799011 |
| keywords[0].display_name | Medicine |
| keywords[1].id | https://openalex.org/keywords/asymptomatic |
| keywords[1].score | 0.793002188205719 |
| keywords[1].display_name | Asymptomatic |
| keywords[2].id | https://openalex.org/keywords/seroconversion |
| keywords[2].score | 0.7122583389282227 |
| keywords[2].display_name | Seroconversion |
| keywords[3].id | https://openalex.org/keywords/vaccination |
| keywords[3].score | 0.6982629299163818 |
| keywords[3].display_name | Vaccination |
| keywords[4].id | https://openalex.org/keywords/incidence |
| keywords[4].score | 0.5879915952682495 |
| keywords[4].display_name | Incidence (geometry) |
| keywords[5].id | https://openalex.org/keywords/prospective-cohort-study |
| keywords[5].score | 0.5810328722000122 |
| keywords[5].display_name | Prospective cohort study |
| keywords[6].id | https://openalex.org/keywords/influenza-vaccine |
| keywords[6].score | 0.5309022665023804 |
| keywords[6].display_name | Influenza vaccine |
| keywords[7].id | https://openalex.org/keywords/cohort-study |
| keywords[7].score | 0.4856092035770416 |
| keywords[7].display_name | Cohort study |
| keywords[8].id | https://openalex.org/keywords/hazard-ratio |
| keywords[8].score | 0.4823422133922577 |
| keywords[8].display_name | Hazard ratio |
| keywords[9].id | https://openalex.org/keywords/internal-medicine |
| keywords[9].score | 0.467384934425354 |
| keywords[9].display_name | Internal medicine |
| keywords[10].id | https://openalex.org/keywords/cohort |
| keywords[10].score | 0.4576683044433594 |
| keywords[10].display_name | Cohort |
| keywords[11].id | https://openalex.org/keywords/immunology |
| keywords[11].score | 0.3689524233341217 |
| keywords[11].display_name | Immunology |
| keywords[12].id | https://openalex.org/keywords/virus |
| keywords[12].score | 0.343239426612854 |
| keywords[12].display_name | Virus |
| keywords[13].id | https://openalex.org/keywords/confidence-interval |
| keywords[13].score | 0.1255633533000946 |
| keywords[13].display_name | Confidence interval |
| language | en |
| locations[0].id | doi:10.1093/cid/ciae491 |
| locations[0].is_oa | True |
| locations[0].source.id | https://openalex.org/S72350973 |
| locations[0].source.issn | 1058-4838, 1537-6591 |
| locations[0].source.type | journal |
| locations[0].source.is_oa | False |
| locations[0].source.issn_l | 1058-4838 |
| locations[0].source.is_core | True |
| locations[0].source.is_in_doaj | False |
| locations[0].source.display_name | Clinical Infectious Diseases |
| locations[0].source.host_organization | https://openalex.org/P4310311648 |
| locations[0].source.host_organization_name | Oxford University Press |
| locations[0].source.host_organization_lineage | https://openalex.org/P4310311648, https://openalex.org/P4310311647 |
| locations[0].source.host_organization_lineage_names | Oxford University Press, University of Oxford |
| locations[0].license | |
| locations[0].pdf_url | https://academic.oup.com/cid/advance-article-pdf/doi/10.1093/cid/ciae491/60029679/ciae491.pdf |
| locations[0].version | publishedVersion |
| locations[0].raw_type | journal-article |
| locations[0].license_id | |
| locations[0].is_accepted | True |
| locations[0].is_published | True |
| locations[0].raw_source_name | Clinical Infectious Diseases |
| locations[0].landing_page_url | https://doi.org/10.1093/cid/ciae491 |
| locations[1].id | pmid:39446477 |
| locations[1].is_oa | False |
| locations[1].source.id | https://openalex.org/S4306525036 |
| locations[1].source.issn | |
| locations[1].source.type | repository |
| locations[1].source.is_oa | False |
| locations[1].source.issn_l | |
| locations[1].source.is_core | False |
| locations[1].source.is_in_doaj | False |
| locations[1].source.display_name | PubMed |
| locations[1].source.host_organization | https://openalex.org/I1299303238 |
| locations[1].source.host_organization_name | National Institutes of Health |
| locations[1].source.host_organization_lineage | https://openalex.org/I1299303238 |
| locations[1].license | |
| locations[1].pdf_url | |
| locations[1].version | publishedVersion |
| locations[1].raw_type | |
| locations[1].license_id | |
| locations[1].is_accepted | True |
| locations[1].is_published | True |
| locations[1].raw_source_name | Clinical infectious diseases : an official publication of the Infectious Diseases Society of America |
| locations[1].landing_page_url | https://pubmed.ncbi.nlm.nih.gov/39446477 |
| indexed_in | crossref, pubmed |
| authorships[0].author.id | https://openalex.org/A5067644323 |
| authorships[0].author.orcid | https://orcid.org/0000-0002-9242-3507 |
| authorships[0].author.display_name | Elizabeth B. White |
| authorships[0].countries | US |
| authorships[0].affiliations[0].institution_ids | https://openalex.org/I4210130616 |
| authorships[0].affiliations[0].raw_affiliation_string | Epidemic Intelligence Service, CDC, Atlanta, Georgia, USA |
| authorships[0].affiliations[1].institution_ids | https://openalex.org/I19085752 |
| authorships[0].affiliations[1].raw_affiliation_string | Influenza Division, National Center for Immunization and Respiratory Diseases, CDC, Atlanta, Georgia, USA |
| authorships[0].institutions[0].id | https://openalex.org/I4210130616 |
| authorships[0].institutions[0].ror | https://ror.org/03v64vs34 |
| authorships[0].institutions[0].type | government |
| authorships[0].institutions[0].lineage | https://openalex.org/I1289490764, https://openalex.org/I1299022934, https://openalex.org/I4210130616 |
| authorships[0].institutions[0].country_code | US |
| authorships[0].institutions[0].display_name | Epidemic Intelligence Service |
| authorships[0].institutions[1].id | https://openalex.org/I19085752 |
| authorships[0].institutions[1].ror | https://ror.org/05je2tx78 |
| authorships[0].institutions[1].type | facility |
| authorships[0].institutions[1].lineage | https://openalex.org/I1289490764, https://openalex.org/I1289490764, https://openalex.org/I1299022934, https://openalex.org/I1299022934, https://openalex.org/I19085752, https://openalex.org/I4210109567 |
| authorships[0].institutions[1].country_code | US |
| authorships[0].institutions[1].display_name | National Center for Immunization and Respiratory Diseases |
| authorships[0].author_position | first |
| authorships[0].raw_author_name | Elizabeth B White |
| authorships[0].is_corresponding | False |
| authorships[0].raw_affiliation_strings | Epidemic Intelligence Service, CDC, Atlanta, Georgia, USA, Influenza Division, National Center for Immunization and Respiratory Diseases, CDC, Atlanta, Georgia, USA |
| authorships[1].author.id | https://openalex.org/A5077971030 |
| authorships[1].author.orcid | https://orcid.org/0000-0002-8656-3538 |
| authorships[1].author.display_name | Lauren Grant |
| authorships[1].countries | US |
| authorships[1].affiliations[0].institution_ids | https://openalex.org/I19085752 |
| authorships[1].affiliations[0].raw_affiliation_string | Influenza Division, National Center for Immunization and Respiratory Diseases, CDC, Atlanta, Georgia, USA |
| authorships[1].institutions[0].id | https://openalex.org/I19085752 |
| authorships[1].institutions[0].ror | https://ror.org/05je2tx78 |
| authorships[1].institutions[0].type | facility |
| authorships[1].institutions[0].lineage | https://openalex.org/I1289490764, https://openalex.org/I1289490764, https://openalex.org/I1299022934, https://openalex.org/I1299022934, https://openalex.org/I19085752, https://openalex.org/I4210109567 |
| authorships[1].institutions[0].country_code | US |
| authorships[1].institutions[0].display_name | National Center for Immunization and Respiratory Diseases |
| authorships[1].author_position | middle |
| authorships[1].raw_author_name | Lauren Grant |
| authorships[1].is_corresponding | False |
| authorships[1].raw_affiliation_strings | Influenza Division, National Center for Immunization and Respiratory Diseases, CDC, Atlanta, Georgia, USA |
| authorships[2].author.id | https://openalex.org/A5002555250 |
| authorships[2].author.orcid | https://orcid.org/0000-0001-9557-2690 |
| authorships[2].author.display_name | Josephine Mak |
| authorships[2].countries | US |
| authorships[2].affiliations[0].institution_ids | https://openalex.org/I19085752 |
| authorships[2].affiliations[0].raw_affiliation_string | Coronavirus and Other Respiratory Viruses Division, National Center for Immunization and Respiratory Diseases, CDC, Atlanta, Georgia, USA |
| authorships[2].institutions[0].id | https://openalex.org/I19085752 |
| authorships[2].institutions[0].ror | https://ror.org/05je2tx78 |
| authorships[2].institutions[0].type | facility |
| authorships[2].institutions[0].lineage | https://openalex.org/I1289490764, https://openalex.org/I1289490764, https://openalex.org/I1299022934, https://openalex.org/I1299022934, https://openalex.org/I19085752, https://openalex.org/I4210109567 |
| authorships[2].institutions[0].country_code | US |
| authorships[2].institutions[0].display_name | National Center for Immunization and Respiratory Diseases |
| authorships[2].author_position | middle |
| authorships[2].raw_author_name | Josephine Mak |
| authorships[2].is_corresponding | False |
| authorships[2].raw_affiliation_strings | Coronavirus and Other Respiratory Viruses Division, National Center for Immunization and Respiratory Diseases, CDC, Atlanta, Georgia, USA |
| authorships[3].author.id | https://openalex.org/A5005863511 |
| authorships[3].author.orcid | https://orcid.org/0000-0003-4503-9745 |
| authorships[3].author.display_name | Lauren E.W. Olsho |
| authorships[3].countries | US |
| authorships[3].affiliations[0].institution_ids | https://openalex.org/I4210152550 |
| authorships[3].affiliations[0].raw_affiliation_string | Abt Associates, Rockville, Maryland, USA |
| authorships[3].institutions[0].id | https://openalex.org/I4210152550 |
| authorships[3].institutions[0].ror | https://ror.org/0502afh35 |
| authorships[3].institutions[0].type | company |
| authorships[3].institutions[0].lineage | https://openalex.org/I4210152550 |
| authorships[3].institutions[0].country_code | US |
| authorships[3].institutions[0].display_name | Abt Global (United States) |
| authorships[3].author_position | middle |
| authorships[3].raw_author_name | Lauren Olsho |
| authorships[3].is_corresponding | False |
| authorships[3].raw_affiliation_strings | Abt Associates, Rockville, Maryland, USA |
| authorships[4].author.id | https://openalex.org/A5087808773 |
| authorships[4].author.orcid | https://orcid.org/0000-0003-1579-2074 |
| authorships[4].author.display_name | Laura Edwards |
| authorships[4].countries | US |
| authorships[4].affiliations[0].institution_ids | https://openalex.org/I4210152550 |
| authorships[4].affiliations[0].raw_affiliation_string | Abt Associates, Rockville, Maryland, USA |
| authorships[4].institutions[0].id | https://openalex.org/I4210152550 |
| authorships[4].institutions[0].ror | https://ror.org/0502afh35 |
| authorships[4].institutions[0].type | company |
| authorships[4].institutions[0].lineage | https://openalex.org/I4210152550 |
| authorships[4].institutions[0].country_code | US |
| authorships[4].institutions[0].display_name | Abt Global (United States) |
| authorships[4].author_position | middle |
| authorships[4].raw_author_name | Laura J Edwards |
| authorships[4].is_corresponding | False |
| authorships[4].raw_affiliation_strings | Abt Associates, Rockville, Maryland, USA |
| authorships[5].author.id | https://openalex.org/A5006755486 |
| authorships[5].author.orcid | https://orcid.org/0000-0001-5747-4643 |
| authorships[5].author.display_name | Allison L. Naleway |
| authorships[5].countries | US |
| authorships[5].affiliations[0].institution_ids | https://openalex.org/I4210114677 |
| authorships[5].affiliations[0].raw_affiliation_string | Kaiser Permanente Center for Health Research, Portland, Oregon, USA |
| authorships[5].institutions[0].id | https://openalex.org/I4210114677 |
| authorships[5].institutions[0].ror | https://ror.org/028gzjv13 |
| authorships[5].institutions[0].type | healthcare |
| authorships[5].institutions[0].lineage | https://openalex.org/I1343052199, https://openalex.org/I4210114677 |
| authorships[5].institutions[0].country_code | US |
| authorships[5].institutions[0].display_name | Kaiser Permanente Center for Health Research |
| authorships[5].author_position | middle |
| authorships[5].raw_author_name | Allison Naleway |
| authorships[5].is_corresponding | False |
| authorships[5].raw_affiliation_strings | Kaiser Permanente Center for Health Research, Portland, Oregon, USA |
| authorships[6].author.id | https://openalex.org/A5077041294 |
| authorships[6].author.orcid | https://orcid.org/0000-0003-2362-9509 |
| authorships[6].author.display_name | Jefferey L. Burgess |
| authorships[6].countries | US |
| authorships[6].affiliations[0].institution_ids | https://openalex.org/I138006243 |
| authorships[6].affiliations[0].raw_affiliation_string | Mel and Enid Zuckerman College of Public Health, University of Arizona, Tucson, Arizona, USA |
| authorships[6].institutions[0].id | https://openalex.org/I138006243 |
| authorships[6].institutions[0].ror | https://ror.org/03m2x1q45 |
| authorships[6].institutions[0].type | education |
| authorships[6].institutions[0].lineage | https://openalex.org/I138006243 |
| authorships[6].institutions[0].country_code | US |
| authorships[6].institutions[0].display_name | University of Arizona |
| authorships[6].author_position | middle |
| authorships[6].raw_author_name | Jefferey L Burgess |
| authorships[6].is_corresponding | False |
| authorships[6].raw_affiliation_strings | Mel and Enid Zuckerman College of Public Health, University of Arizona, Tucson, Arizona, USA |
| authorships[7].author.id | https://openalex.org/A5090770917 |
| authorships[7].author.orcid | https://orcid.org/0000-0001-7624-312X |
| authorships[7].author.display_name | Katherine Ellingson |
| authorships[7].countries | US |
| authorships[7].affiliations[0].institution_ids | https://openalex.org/I138006243 |
| authorships[7].affiliations[0].raw_affiliation_string | Mel and Enid Zuckerman College of Public Health, University of Arizona, Tucson, Arizona, USA |
| authorships[7].institutions[0].id | https://openalex.org/I138006243 |
| authorships[7].institutions[0].ror | https://ror.org/03m2x1q45 |
| authorships[7].institutions[0].type | education |
| authorships[7].institutions[0].lineage | https://openalex.org/I138006243 |
| authorships[7].institutions[0].country_code | US |
| authorships[7].institutions[0].display_name | University of Arizona |
| authorships[7].author_position | middle |
| authorships[7].raw_author_name | Katherine D Ellingson |
| authorships[7].is_corresponding | False |
| authorships[7].raw_affiliation_strings | Mel and Enid Zuckerman College of Public Health, University of Arizona, Tucson, Arizona, USA |
| authorships[8].author.id | https://openalex.org/A5003738991 |
| authorships[8].author.orcid | https://orcid.org/0000-0002-4130-0793 |
| authorships[8].author.display_name | Harmony L. Tyner |
| authorships[8].countries | US |
| authorships[8].affiliations[0].institution_ids | https://openalex.org/I1339091601, https://openalex.org/I4210105746 |
| authorships[8].affiliations[0].raw_affiliation_string | St. Luke's Regional Health Care System, Duluth, Minnesota, USA |
| authorships[8].institutions[0].id | https://openalex.org/I4210105746 |
| authorships[8].institutions[0].ror | https://ror.org/01d1vqp66 |
| authorships[8].institutions[0].type | healthcare |
| authorships[8].institutions[0].lineage | https://openalex.org/I4210105746 |
| authorships[8].institutions[0].country_code | US |
| authorships[8].institutions[0].display_name | Regional Health |
| authorships[8].institutions[1].id | https://openalex.org/I1339091601 |
| authorships[8].institutions[1].ror | https://ror.org/0127qs140 |
| authorships[8].institutions[1].type | healthcare |
| authorships[8].institutions[1].lineage | https://openalex.org/I1339091601 |
| authorships[8].institutions[1].country_code | US |
| authorships[8].institutions[1].display_name | Saint Luke's Health System |
| authorships[8].author_position | middle |
| authorships[8].raw_author_name | Harmony Tyner |
| authorships[8].is_corresponding | False |
| authorships[8].raw_affiliation_strings | St. Luke's Regional Health Care System, Duluth, Minnesota, USA |
| authorships[9].author.id | https://openalex.org/A5081844185 |
| authorships[9].author.orcid | https://orcid.org/0000-0002-3952-9230 |
| authorships[9].author.display_name | Manjusha Gaglani |
| authorships[9].countries | US |
| authorships[9].affiliations[0].institution_ids | https://openalex.org/I181547552 |
| authorships[9].affiliations[0].raw_affiliation_string | Baylor College of Medicine, Temple, Texas, USA |
| authorships[9].institutions[0].id | https://openalex.org/I181547552 |
| authorships[9].institutions[0].ror | https://ror.org/02pttbw34 |
| authorships[9].institutions[0].type | education |
| authorships[9].institutions[0].lineage | https://openalex.org/I181547552, https://openalex.org/I2801539370 |
| authorships[9].institutions[0].country_code | US |
| authorships[9].institutions[0].display_name | Baylor College of Medicine |
| authorships[9].author_position | middle |
| authorships[9].raw_author_name | Manjusha Gaglani |
| authorships[9].is_corresponding | False |
| authorships[9].raw_affiliation_strings | Baylor College of Medicine, Temple, Texas, USA |
| authorships[10].author.id | https://openalex.org/A5089314021 |
| authorships[10].author.orcid | https://orcid.org/0000-0003-3480-849X |
| authorships[10].author.display_name | Karen Lutrick |
| authorships[10].countries | US |
| authorships[10].affiliations[0].institution_ids | https://openalex.org/I138006243 |
| authorships[10].affiliations[0].raw_affiliation_string | College of Medicine-Tucson, University of Arizona, Tucson, Arizona, USA |
| authorships[10].institutions[0].id | https://openalex.org/I138006243 |
| authorships[10].institutions[0].ror | https://ror.org/03m2x1q45 |
| authorships[10].institutions[0].type | education |
| authorships[10].institutions[0].lineage | https://openalex.org/I138006243 |
| authorships[10].institutions[0].country_code | US |
| authorships[10].institutions[0].display_name | University of Arizona |
| authorships[10].author_position | middle |
| authorships[10].raw_author_name | Karen Lutrick |
| authorships[10].is_corresponding | False |
| authorships[10].raw_affiliation_strings | College of Medicine-Tucson, University of Arizona, Tucson, Arizona, USA |
| authorships[11].author.id | https://openalex.org/A5051312994 |
| authorships[11].author.orcid | https://orcid.org/0000-0002-5960-1308 |
| authorships[11].author.display_name | Alberto J. Caban‐Martinez |
| authorships[11].countries | US |
| authorships[11].affiliations[0].institution_ids | https://openalex.org/I145608581 |
| authorships[11].affiliations[0].raw_affiliation_string | University of Miami, Miami, Florida, USA |
| authorships[11].institutions[0].id | https://openalex.org/I145608581 |
| authorships[11].institutions[0].ror | https://ror.org/02dgjyy92 |
| authorships[11].institutions[0].type | education |
| authorships[11].institutions[0].lineage | https://openalex.org/I145608581 |
| authorships[11].institutions[0].country_code | US |
| authorships[11].institutions[0].display_name | University of Miami |
| authorships[11].author_position | middle |
| authorships[11].raw_author_name | Alberto Caban-Martinez |
| authorships[11].is_corresponding | False |
| authorships[11].raw_affiliation_strings | University of Miami, Miami, Florida, USA |
| authorships[12].author.id | https://openalex.org/A5069706670 |
| authorships[12].author.orcid | https://orcid.org/0000-0002-4411-0370 |
| authorships[12].author.display_name | Gabriella Newes‐Adeyi |
| authorships[12].countries | US |
| authorships[12].affiliations[0].institution_ids | https://openalex.org/I4210152550 |
| authorships[12].affiliations[0].raw_affiliation_string | Abt Associates, Rockville, Maryland, USA |
| authorships[12].institutions[0].id | https://openalex.org/I4210152550 |
| authorships[12].institutions[0].ror | https://ror.org/0502afh35 |
| authorships[12].institutions[0].type | company |
| authorships[12].institutions[0].lineage | https://openalex.org/I4210152550 |
| authorships[12].institutions[0].country_code | US |
| authorships[12].institutions[0].display_name | Abt Global (United States) |
| authorships[12].author_position | middle |
| authorships[12].raw_author_name | Gabriella Newes-Adeyi |
| authorships[12].is_corresponding | False |
| authorships[12].raw_affiliation_strings | Abt Associates, Rockville, Maryland, USA |
| authorships[13].author.id | https://openalex.org/A5033921576 |
| authorships[13].author.orcid | https://orcid.org/0000-0003-3484-276X |
| authorships[13].author.display_name | Jazmin Duque |
| authorships[13].countries | US |
| authorships[13].affiliations[0].institution_ids | https://openalex.org/I4210152550 |
| authorships[13].affiliations[0].raw_affiliation_string | Abt Associates, Rockville, Maryland, USA |
| authorships[13].institutions[0].id | https://openalex.org/I4210152550 |
| authorships[13].institutions[0].ror | https://ror.org/0502afh35 |
| authorships[13].institutions[0].type | company |
| authorships[13].institutions[0].lineage | https://openalex.org/I4210152550 |
| authorships[13].institutions[0].country_code | US |
| authorships[13].institutions[0].display_name | Abt Global (United States) |
| authorships[13].author_position | middle |
| authorships[13].raw_author_name | Jazmin Duque |
| authorships[13].is_corresponding | False |
| authorships[13].raw_affiliation_strings | Abt Associates, Rockville, Maryland, USA |
| authorships[14].author.id | https://openalex.org/A5072826416 |
| authorships[14].author.orcid | https://orcid.org/0000-0002-8500-2886 |
| authorships[14].author.display_name | Sarang K. Yoon |
| authorships[14].countries | US |
| authorships[14].affiliations[0].institution_ids | https://openalex.org/I223532165 |
| authorships[14].affiliations[0].raw_affiliation_string | University of Utah Health, Salt Lake City, Utah, USA |
| authorships[14].institutions[0].id | https://openalex.org/I223532165 |
| authorships[14].institutions[0].ror | https://ror.org/03r0ha626 |
| authorships[14].institutions[0].type | education |
| authorships[14].institutions[0].lineage | https://openalex.org/I223532165 |
| authorships[14].institutions[0].country_code | US |
| authorships[14].institutions[0].display_name | University of Utah |
| authorships[14].author_position | middle |
| authorships[14].raw_author_name | Sarang K Yoon |
| authorships[14].is_corresponding | False |
| authorships[14].raw_affiliation_strings | University of Utah Health, Salt Lake City, Utah, USA |
| authorships[15].author.id | https://openalex.org/A5072352114 |
| authorships[15].author.orcid | https://orcid.org/0000-0003-2320-3567 |
| authorships[15].author.display_name | Andrew L. Phillips |
| authorships[15].countries | US |
| authorships[15].affiliations[0].institution_ids | https://openalex.org/I223532165 |
| authorships[15].affiliations[0].raw_affiliation_string | University of Utah Health, Salt Lake City, Utah, USA |
| authorships[15].institutions[0].id | https://openalex.org/I223532165 |
| authorships[15].institutions[0].ror | https://ror.org/03r0ha626 |
| authorships[15].institutions[0].type | education |
| authorships[15].institutions[0].lineage | https://openalex.org/I223532165 |
| authorships[15].institutions[0].country_code | US |
| authorships[15].institutions[0].display_name | University of Utah |
| authorships[15].author_position | middle |
| authorships[15].raw_author_name | Andrew L Phillips |
| authorships[15].is_corresponding | False |
| authorships[15].raw_affiliation_strings | University of Utah Health, Salt Lake City, Utah, USA |
| authorships[16].author.id | https://openalex.org/A5023200067 |
| authorships[16].author.orcid | https://orcid.org/0000-0001-8958-0336 |
| authorships[16].author.display_name | Mark S. Thompson |
| authorships[16].countries | US |
| authorships[16].affiliations[0].institution_ids | https://openalex.org/I1333523220 |
| authorships[16].affiliations[0].raw_affiliation_string | Westat, Rockville, Maryland, USA |
| authorships[16].institutions[0].id | https://openalex.org/I1333523220 |
| authorships[16].institutions[0].ror | https://ror.org/00wt7xg39 |
| authorships[16].institutions[0].type | company |
| authorships[16].institutions[0].lineage | https://openalex.org/I1333523220 |
| authorships[16].institutions[0].country_code | US |
| authorships[16].institutions[0].display_name | Westat (United States) |
| authorships[16].author_position | middle |
| authorships[16].raw_author_name | Mark Thompson |
| authorships[16].is_corresponding | False |
| authorships[16].raw_affiliation_strings | Westat, Rockville, Maryland, USA |
| authorships[17].author.id | https://openalex.org/A5022861785 |
| authorships[17].author.orcid | https://orcid.org/0000-0003-2684-8846 |
| authorships[17].author.display_name | Amadea Britton |
| authorships[17].countries | US |
| authorships[17].affiliations[0].institution_ids | https://openalex.org/I19085752 |
| authorships[17].affiliations[0].raw_affiliation_string | Coronavirus and Other Respiratory Viruses Division, National Center for Immunization and Respiratory Diseases, CDC, Atlanta, Georgia, USA |
| authorships[17].institutions[0].id | https://openalex.org/I19085752 |
| authorships[17].institutions[0].ror | https://ror.org/05je2tx78 |
| authorships[17].institutions[0].type | facility |
| authorships[17].institutions[0].lineage | https://openalex.org/I1289490764, https://openalex.org/I1289490764, https://openalex.org/I1299022934, https://openalex.org/I1299022934, https://openalex.org/I19085752, https://openalex.org/I4210109567 |
| authorships[17].institutions[0].country_code | US |
| authorships[17].institutions[0].display_name | National Center for Immunization and Respiratory Diseases |
| authorships[17].author_position | middle |
| authorships[17].raw_author_name | Amadea Britton |
| authorships[17].is_corresponding | False |
| authorships[17].raw_affiliation_strings | Coronavirus and Other Respiratory Viruses Division, National Center for Immunization and Respiratory Diseases, CDC, Atlanta, Georgia, USA |
| authorships[18].author.id | https://openalex.org/A5011537093 |
| authorships[18].author.orcid | https://orcid.org/0000-0001-5041-308X |
| authorships[18].author.display_name | Brendan Flannery |
| authorships[18].countries | US |
| authorships[18].affiliations[0].institution_ids | https://openalex.org/I19085752 |
| authorships[18].affiliations[0].raw_affiliation_string | Influenza Division, National Center for Immunization and Respiratory Diseases, CDC, Atlanta, Georgia, USA |
| authorships[18].institutions[0].id | https://openalex.org/I19085752 |
| authorships[18].institutions[0].ror | https://ror.org/05je2tx78 |
| authorships[18].institutions[0].type | facility |
| authorships[18].institutions[0].lineage | https://openalex.org/I1289490764, https://openalex.org/I1289490764, https://openalex.org/I1299022934, https://openalex.org/I1299022934, https://openalex.org/I19085752, https://openalex.org/I4210109567 |
| authorships[18].institutions[0].country_code | US |
| authorships[18].institutions[0].display_name | National Center for Immunization and Respiratory Diseases |
| authorships[18].author_position | middle |
| authorships[18].raw_author_name | Brendan Flannery |
| authorships[18].is_corresponding | False |
| authorships[18].raw_affiliation_strings | Influenza Division, National Center for Immunization and Respiratory Diseases, CDC, Atlanta, Georgia, USA |
| authorships[19].author.id | https://openalex.org/A5077089490 |
| authorships[19].author.orcid | https://orcid.org/0000-0002-0620-6451 |
| authorships[19].author.display_name | Ashley Fowlkes |
| authorships[19].countries | US |
| authorships[19].affiliations[0].institution_ids | https://openalex.org/I19085752 |
| authorships[19].affiliations[0].raw_affiliation_string | Influenza Division, National Center for Immunization and Respiratory Diseases, CDC, Atlanta, Georgia, USA |
| authorships[19].institutions[0].id | https://openalex.org/I19085752 |
| authorships[19].institutions[0].ror | https://ror.org/05je2tx78 |
| authorships[19].institutions[0].type | facility |
| authorships[19].institutions[0].lineage | https://openalex.org/I1289490764, https://openalex.org/I1289490764, https://openalex.org/I1299022934, https://openalex.org/I1299022934, https://openalex.org/I19085752, https://openalex.org/I4210109567 |
| authorships[19].institutions[0].country_code | US |
| authorships[19].institutions[0].display_name | National Center for Immunization and Respiratory Diseases |
| authorships[19].author_position | last |
| authorships[19].raw_author_name | Ashley Fowlkes |
| authorships[19].is_corresponding | False |
| authorships[19].raw_affiliation_strings | Influenza Division, National Center for Immunization and Respiratory Diseases, CDC, Atlanta, Georgia, USA |
| has_content.pdf | True |
| has_content.grobid_xml | False |
| is_paratext | False |
| open_access.is_oa | True |
| open_access.oa_url | https://academic.oup.com/cid/advance-article-pdf/doi/10.1093/cid/ciae491/60029679/ciae491.pdf |
| open_access.oa_status | bronze |
| open_access.any_repository_has_fulltext | False |
| created_date | 2025-10-10T00:00:00 |
| display_name | Influenza Vaccine Effectiveness Against Illness and Asymptomatic Infection in 2022–2023: A Prospective Cohort Study |
| has_fulltext | False |
| is_retracted | False |
| updated_date | 2025-11-06T03:46:38.306776 |
| primary_topic.id | https://openalex.org/T10167 |
| primary_topic.field.id | https://openalex.org/fields/27 |
| primary_topic.field.display_name | Medicine |
| primary_topic.score | 1.0 |
| primary_topic.domain.id | https://openalex.org/domains/4 |
| primary_topic.domain.display_name | Health Sciences |
| primary_topic.subfield.id | https://openalex.org/subfields/2713 |
| primary_topic.subfield.display_name | Epidemiology |
| primary_topic.display_name | Influenza Virus Research Studies |
| related_works | https://openalex.org/W4206105795, https://openalex.org/W1975432501, https://openalex.org/W2097753790, https://openalex.org/W2049776456, https://openalex.org/W1627705222, https://openalex.org/W2781494228, https://openalex.org/W2026567288, https://openalex.org/W3088609705, https://openalex.org/W1968396325, https://openalex.org/W2169729194 |
| cited_by_count | 6 |
| counts_by_year[0].year | 2025 |
| counts_by_year[0].cited_by_count | 6 |
| locations_count | 2 |
| best_oa_location.id | doi:10.1093/cid/ciae491 |
| best_oa_location.is_oa | True |
| best_oa_location.source.id | https://openalex.org/S72350973 |
| best_oa_location.source.issn | 1058-4838, 1537-6591 |
| best_oa_location.source.type | journal |
| best_oa_location.source.is_oa | False |
| best_oa_location.source.issn_l | 1058-4838 |
| best_oa_location.source.is_core | True |
| best_oa_location.source.is_in_doaj | False |
| best_oa_location.source.display_name | Clinical Infectious Diseases |
| best_oa_location.source.host_organization | https://openalex.org/P4310311648 |
| best_oa_location.source.host_organization_name | Oxford University Press |
| best_oa_location.source.host_organization_lineage | https://openalex.org/P4310311648, https://openalex.org/P4310311647 |
| best_oa_location.source.host_organization_lineage_names | Oxford University Press, University of Oxford |
| best_oa_location.license | |
| best_oa_location.pdf_url | https://academic.oup.com/cid/advance-article-pdf/doi/10.1093/cid/ciae491/60029679/ciae491.pdf |
| best_oa_location.version | publishedVersion |
| best_oa_location.raw_type | journal-article |
| best_oa_location.license_id | |
| best_oa_location.is_accepted | True |
| best_oa_location.is_published | True |
| best_oa_location.raw_source_name | Clinical Infectious Diseases |
| best_oa_location.landing_page_url | https://doi.org/10.1093/cid/ciae491 |
| primary_location.id | doi:10.1093/cid/ciae491 |
| primary_location.is_oa | True |
| primary_location.source.id | https://openalex.org/S72350973 |
| primary_location.source.issn | 1058-4838, 1537-6591 |
| primary_location.source.type | journal |
| primary_location.source.is_oa | False |
| primary_location.source.issn_l | 1058-4838 |
| primary_location.source.is_core | True |
| primary_location.source.is_in_doaj | False |
| primary_location.source.display_name | Clinical Infectious Diseases |
| primary_location.source.host_organization | https://openalex.org/P4310311648 |
| primary_location.source.host_organization_name | Oxford University Press |
| primary_location.source.host_organization_lineage | https://openalex.org/P4310311648, https://openalex.org/P4310311647 |
| primary_location.source.host_organization_lineage_names | Oxford University Press, University of Oxford |
| primary_location.license | |
| primary_location.pdf_url | https://academic.oup.com/cid/advance-article-pdf/doi/10.1093/cid/ciae491/60029679/ciae491.pdf |
| primary_location.version | publishedVersion |
| primary_location.raw_type | journal-article |
| primary_location.license_id | |
| primary_location.is_accepted | True |
| primary_location.is_published | True |
| primary_location.raw_source_name | Clinical Infectious Diseases |
| primary_location.landing_page_url | https://doi.org/10.1093/cid/ciae491 |
| publication_date | 2024-10-23 |
| publication_year | 2024 |
| referenced_works | https://openalex.org/W4220977983, https://openalex.org/W4389886011, https://openalex.org/W2462995208, https://openalex.org/W2164621648, https://openalex.org/W2946667882, https://openalex.org/W3207147417, https://openalex.org/W3165521090, https://openalex.org/W3141986261, https://openalex.org/W3176239731, https://openalex.org/W3193938173, https://openalex.org/W1986705681, https://openalex.org/W2264767503, https://openalex.org/W1960083897, https://openalex.org/W4293102569, https://openalex.org/W4285793324, https://openalex.org/W4321610323, https://openalex.org/W4389333763, https://openalex.org/W4389262217, https://openalex.org/W2804447836, https://openalex.org/W3202755137, https://openalex.org/W4212896891, https://openalex.org/W4205157734, https://openalex.org/W4385142501, https://openalex.org/W2258623704 |
| referenced_works_count | 24 |
| abstract_inverted_index.7 | 51 |
| abstract_inverted_index.A | 145, 183 |
| abstract_inverted_index.a | 34 |
| abstract_inverted_index.(1 | 161 |
| abstract_inverted_index.In | 38, 169 |
| abstract_inverted_index.US | 52 |
| abstract_inverted_index.VE | 27, 159 |
| abstract_inverted_index.We | 23, 129, 157 |
| abstract_inverted_index.as | 75, 108, 160 |
| abstract_inverted_index.at | 43 |
| abstract_inverted_index.be | 21 |
| abstract_inverted_index.by | 139, 143 |
| abstract_inverted_index.in | 33 |
| abstract_inverted_index.of | 4, 47, 84, 120, 172, 192, 217, 239 |
| abstract_inverted_index.on | 14 |
| abstract_inverted_index.or | 79, 124 |
| abstract_inverted_index.to | 255 |
| abstract_inverted_index.× | 166 |
| abstract_inverted_index.000 | 208, 228 |
| abstract_inverted_index.100 | 207, 227 |
| abstract_inverted_index.201 | 187 |
| abstract_inverted_index.263 | 180 |
| abstract_inverted_index.269 | 171 |
| abstract_inverted_index.8.0 | 223 |
| abstract_inverted_index.95% | 213, 231 |
| abstract_inverted_index.CI: | 214, 232 |
| abstract_inverted_index.Cox | 148 |
| abstract_inverted_index.and | 19, 30, 58, 90, 101, 142, 155, 186, 203 |
| abstract_inverted_index.but | 241 |
| abstract_inverted_index.end | 126 |
| abstract_inverted_index.for | 61, 153 |
| abstract_inverted_index.had | 176 |
| abstract_inverted_index.may | 20 |
| abstract_inverted_index.not | 242 |
| abstract_inverted_index.per | 206, 226 |
| abstract_inverted_index.the | 39, 82, 111 |
| abstract_inverted_index.was | 106, 201, 222 |
| abstract_inverted_index.− | 162 |
| abstract_inverted_index.(May | 127 |
| abstract_inverted_index.(VE) | 7 |
| abstract_inverted_index.(VE: | 211, 229 |
| abstract_inverted_index.11.6 | 225 |
| abstract_inverted_index.13%; | 230 |
| abstract_inverted_index.23.7 | 202 |
| abstract_inverted_index.33.2 | 204 |
| abstract_inverted_index.3785 | 173 |
| abstract_inverted_index.38%; | 212 |
| abstract_inverted_index.date | 119 |
| abstract_inverted_index.days | 109 |
| abstract_inverted_index.from | 110, 253 |
| abstract_inverted_index.have | 16 |
| abstract_inverted_index.most | 94 |
| abstract_inverted_index.risk | 46 |
| abstract_inverted_index.site | 154 |
| abstract_inverted_index.that | 248 |
| abstract_inverted_index.week | 83 |
| abstract_inverted_index.were | 73 |
| abstract_inverted_index.(75%) | 188 |
| abstract_inverted_index.(98%) | 181 |
| abstract_inverted_index.(≥1 | 77 |
| abstract_inverted_index.100%. | 167 |
| abstract_inverted_index.2022) | 117 |
| abstract_inverted_index.49%). | 234 |
| abstract_inverted_index.among | 133, 196 |
| abstract_inverted_index.based | 13 |
| abstract_inverted_index.chain | 64 |
| abstract_inverted_index.nasal | 59 |
| abstract_inverted_index.sites | 53, 95 |
| abstract_inverted_index.start | 115 |
| abstract_inverted_index.study | 122 |
| abstract_inverted_index.swabs | 60 |
| abstract_inverted_index.using | 147 |
| abstract_inverted_index.virus | 11, 71, 184, 220, 245 |
| abstract_inverted_index.(7.1%) | 174 |
| abstract_inverted_index.2023). | 128 |
| abstract_inverted_index.across | 50 |
| abstract_inverted_index.adults | 42 |
| abstract_inverted_index.during | 81 |
| abstract_inverted_index.hazard | 164 |
| abstract_inverted_index.ratio) | 165 |
| abstract_inverted_index.record | 100 |
| abstract_inverted_index.season | 114, 125 |
| abstract_inverted_index.total, | 170 |
| abstract_inverted_index.varied | 17 |
| abstract_inverted_index.versus | 135, 198, 224 |
| abstract_inverted_index.weekly | 55 |
| abstract_inverted_index.widely | 18 |
| abstract_inverted_index.Methods | 37 |
| abstract_inverted_index.Results | 168 |
| abstract_inverted_index.against | 8, 28 |
| abstract_inverted_index.biased. | 22 |
| abstract_inverted_index.cohort, | 41 |
| abstract_inverted_index.cohort. | 36 |
| abstract_inverted_index.hazards | 150 |
| abstract_inverted_index.illness | 29, 195 |
| abstract_inverted_index.medical | 99 |
| abstract_inverted_index.reduced | 237 |
| abstract_inverted_index.reports | 57 |
| abstract_inverted_index.reverse | 62 |
| abstract_inverted_index.review. | 104 |
| abstract_inverted_index.status, | 141 |
| abstract_inverted_index.symptom | 56, 140 |
| abstract_inverted_index.through | 92, 98, 118 |
| abstract_inverted_index.vaccine | 5 |
| abstract_inverted_index.−47%, | 233 |
| abstract_inverted_index.(RT-PCR) | 66 |
| abstract_inverted_index.Abstract | 0 |
| abstract_inverted_index.Previous | 2 |
| abstract_inverted_index.adjusted | 152, 163 |
| abstract_inverted_index.compared | 130 |
| abstract_inverted_index.episodes | 205 |
| abstract_inverted_index.exposure | 49 |
| abstract_inverted_index.illness. | 256 |
| abstract_inverted_index.overall, | 138 |
| abstract_inverted_index.provided | 54 |
| abstract_inverted_index.reaction | 65 |
| abstract_inverted_index.registry | 103 |
| abstract_inverted_index.reported | 87 |
| abstract_inverted_index.subtype, | 146 |
| abstract_inverted_index.surveys; | 93 |
| abstract_inverted_index.symptom) | 78 |
| abstract_inverted_index.testing. | 68, 85 |
| abstract_inverted_index.verified | 96 |
| abstract_inverted_index.Incidence | 191, 216 |
| abstract_inverted_index.estimated | 24, 158 |
| abstract_inverted_index.estimates | 3 |
| abstract_inverted_index.incidence | 132, 238 |
| abstract_inverted_index.including | 179 |
| abstract_inverted_index.increased | 44 |
| abstract_inverted_index.infection | 12, 32, 221, 254 |
| abstract_inverted_index.influenza | 10, 26, 48, 67, 70, 113, 131, 144, 182, 194, 219, 244, 249 |
| abstract_inverted_index.Background | 1 |
| abstract_inverted_index.attenuates | 251 |
| abstract_inverted_index.calculated | 107 |
| abstract_inverted_index.classified | 74 |
| abstract_inverted_index.illnesses. | 190 |
| abstract_inverted_index.infection, | 121, 246 |
| abstract_inverted_index.infections | 72, 185 |
| abstract_inverted_index.influenza, | 178 |
| abstract_inverted_index.regression | 151 |
| abstract_inverted_index.suggesting | 247 |
| abstract_inverted_index.vaccinated | 134, 197 |
| abstract_inverted_index.15%–55%). | 215 |
| abstract_inverted_index.2022–2023 | 25 |
| abstract_inverted_index.Conclusions | 235 |
| abstract_inverted_index.Person-time | 105 |
| abstract_inverted_index.Vaccination | 236 |
| abstract_inverted_index.demographic | 88 |
| abstract_inverted_index.information | 89 |
| abstract_inverted_index.occupation. | 156 |
| abstract_inverted_index.progression | 252 |
| abstract_inverted_index.prospective | 35 |
| abstract_inverted_index.symptomatic | 76, 189, 240 |
| abstract_inverted_index.vaccination | 91, 97, 250 |
| abstract_inverted_index.withdrawal, | 123 |
| abstract_inverted_index.Participants | 86 |
| abstract_inverted_index.asymptomatic | 9, 31, 80, 218, 243 |
| abstract_inverted_index.immunization | 102 |
| abstract_inverted_index.occupational | 45 |
| abstract_inverted_index.participants | 137, 175, 200 |
| abstract_inverted_index.person-days, | 209 |
| abstract_inverted_index.proportional | 149 |
| abstract_inverted_index.respectively | 210 |
| abstract_inverted_index.unvaccinated | 136, 199 |
| abstract_inverted_index.effectiveness | 6 |
| abstract_inverted_index.site-specific | 112 |
| abstract_inverted_index.HEROES-RECOVER | 40 |
| abstract_inverted_index.seroconversion | 15 |
| abstract_inverted_index.(September–October | 116 |
| abstract_inverted_index.Laboratory-confirmed | 69 |
| abstract_inverted_index.laboratory-confirmed | 177, 193 |
| abstract_inverted_index.transcription–polymerase | 63 |
| cited_by_percentile_year.max | 99 |
| cited_by_percentile_year.min | 98 |
| countries_distinct_count | 1 |
| institutions_distinct_count | 20 |
| sustainable_development_goals[0].id | https://metadata.un.org/sdg/3 |
| sustainable_development_goals[0].score | 0.8199999928474426 |
| sustainable_development_goals[0].display_name | Good health and well-being |
| citation_normalized_percentile.value | 0.92533548 |
| citation_normalized_percentile.is_in_top_1_percent | False |
| citation_normalized_percentile.is_in_top_10_percent | True |